Goserelin used with ER/PR-negatives?


Question from Jaclin: I would like to know if goserelin is common to use in hormone-receptor-negative breast cancer?
Answers - Kathy D. Miller, M.D. Goserelin (brand name: Zoladex) works by stopping the ovaries from producing estrogen, so it has only been effective in women with hormone-receptor-positive cancers.

On Wednesday, November 19, 2005, our Ask-the-Expert Online Conference was called Hormone-Receptor-Negative Breast CancerKathy D. Miller, M.D., Marisa Weiss, M.D., and moderator Jennifer Armstrong, M.D. answered your questions about a wide range of issues related to hormone-receptor-negative breast cancer.

The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.

Was this resource helpful?

Yes No
C3a
C3b
Evergreen-donate
Back to Top